Nabity-Jensen Investment Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16M Sell
4,569
-5
-0.1% -$1.17K 0.71% 29
2026
Q1
$1.12M Buy
4,574
+13
+0.3% +$3.03K 0.78% 30
2025
Q4
$944K Buy
4,561
+33
+0.7% +$6.53K 0.64% 33
2025
Q3
$840K Buy
4,528
+68
+2% +$11.7K 0.58% 35
2025
Q2
$681K Sell
4,460
-164
-4% -$25.2K 0.5% 37
2025
Q1
$767K Buy
4,624
+69
+2% +$10.8K 0.61% 34
2024
Q4
$659K Buy
4,555
+182
+4% +$28.2K 0.5% 40
2024
Q3
$709K Buy
4,373
+272
+7% +$43.3K 0.54% 37
2024
Q2
$599K Sell
4,101
-1
-0% -$149 0.49% 39
2024
Q1
$649K Hold
4,102
0.53% 37
2023
Q4
$643K Buy
+4,102
New +$629K 0.58% 35

Other funds holding JNJ

Nabity-Jensen Investment Management's JNJ Position: Q2 2026 in Review

Nabity-Jensen Investment Management reduced its Johnson & Johnson (JNJ) stake by 0.11% in Q2 2026, selling an estimated $1.17K and leaving 4,569 shares worth $1.16M. The position accounts for 0.71% of the portfolio, ranked #29.

Nabity-Jensen Investment Management first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 1,808 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Nabity-Jensen Investment Management held 4,569 shares of Johnson & Johnson worth $1.16M as of Q2 2026.
  • Nabity-Jensen Investment Management sold 5 Johnson & Johnson shares in Q2 2026, an estimated $1.17K.
  • Johnson & Johnson made up 0.71% of Nabity-Jensen Investment Management's portfolio in Q2 2026, its #29 holding.
  • Nabity-Jensen Investment Management first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 1,808 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Nabity-Jensen Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.